Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction

Biochemical and Biophysical Research Communications

Volumn 352, Issue 1, 2007, Pages 251-258

  Sjöwall, Christopher ^a   Wetterö, Jonas ^a   Bengtsson, Torbjörn ^b   Askendal, Agneta ^c   Almroth, Gunnel ^a   Skogh, Thomas ^a   Tengvall, Pentti ^c  

^a Division of Rheumatology   (Sweden)

^b Cardiovascular Inflammation Research Centre   (Sweden)

^c Laboratory of Applied Physics   (Sweden)

Author keywords

C reactive protein; C1q; Complement; Inflammation; Opsonization; Pentraxins; Systemic lupus erythematosus

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C4; COMPLEMENT FACTOR H; FIBRINOGEN; KEYHOLE LIMPET HEMOCYANIN; PHOSPHORYLCHOLINE;

ARTICLE; BLOOD SAMPLING; COMPLEMENT ACTIVATION; CONCENTRATION RESPONSE; CONJUGATION; CONTROLLED STUDY; CROSS LINKING; DOWN REGULATION; ELLIPSOMETRY; HUMAN; IMMUNODIFFUSION; INFLAMMATION; OPSONIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SOLID; SYSTEMIC LUPUS ERYTHEMATOSUS;

C-REACTIVE PROTEIN; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; HUMANS; IMMUNOGLOBULIN G; PHOSPHORYLCHOLINE; PROTEIN BINDING; SILICON;

EID: 33751433364     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.11.013     Document Type: Article

References (48)

1. Gewurz H., Ying S.C., Jiang H., and Lint T.F. Nonimmune activation of the classical complement pathway. Behring. Inst. Mitt. 93 (1993) 138-147
2. Niculescu F., and Rus H. Complement activation and atherosclerosis. Mol. Immunol. 36 (1999) 949-955
3. Ikeda K., Sannoh T., Kawasaki N., Kawasaki T., and Yamashina I. Serum lectin with known structure activates complement through the classical pathway. J. Biol. Chem. 262 (1987) 7451-7454
4. Sjöholm A.G., Jönsson G., Braconier J.H., Sturfelt G., and Truedsson L. Complement deficiency and disease: an update. Mol. Immunol. 43 (2006) 78-85
5. Molenaar E.T., Voskuyl A.E., Familian A., van Mierlo G.J., Dijkmans B.A., and Hack C.E. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein. Arthritis Rheum. 44 (2001) 997-1002
6. Compston D.A., Morgan B.P., Campbell A.K., Wilkins P., Cole G., Thomas N.D., and Jasani B. Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol. Appl. Neurobiol. 15 (1989) 307-316
7. Volanakis J.E. Human C-reactive protein: expression, structure, and function. Mol. Immunol. 38 (2001) 189-197
8. Sjöwall C., Bengtsson T., and Skogh T. CRP and anti-CRP autoantibodies in systemic lupus erythematosus. Curr. Rheumatol. Rev. 1 (2005) 81-89
9. Kleemann R., Gervois P.P., Verschuren L., Staels B., Princen H.M., and Kooistra T. Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFκB-C/EBP-β complex formation. Blood 101 (2003) 545-551
10. Manolov D.E., Röcker C., Hombach V., Nienhaus U., and Torzewski J. Ultrasensitive confocal fluorescence microscopy of C-reactive protein interacting with FcγRIIa. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 2372-2377
11. Taskinen S.S., Hyvönen M., Kovanen P.T., Meri S., and Pentikäinen M.O. C-reactive protein binds to the 3β-OH group of cholesterol in LDL particles. Biochem. Biophys. Res. Commun. 329 (2005) 1208-1216
12. Verma S., Szmitko P.E., and Yeh E.T. C-reactive protein: structure affects function. Circulation 109 (2004) 1914-1917
13. Gabay C., Roux-Lombard P., de Moerloose P., Dayer J.M., Vischer T., and Guerne P.A. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. J. Rheumatol. 20 (1993) 815-821
14. Kaplan M.H., and Volanakis J.E. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J. Immunol. 112 (1974) 2135-2147
15. Siegel J., Rent R., and Gewurz H. Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera. J. Exp. Med. 140 (1974) 631-647
16. Berman S., Gewurz H., and Mold C. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis. J. Immunol. 136 (1986) 1354-1359
17. Jarva H., Jokiranta T.S., Hellwage J., Zipfel P.F., and Meri S. Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11. J. Immunol. 163 (1999) 3957-3962
18. Giannakis E., Jokiranta T.S., Male D.A., Ranganathan S., Ormsby R.J., Fischetti V.A., Mold C., and Gordon D.L. A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein. Eur. J. Immunol. 33 (2003) 962-969
19. Potempa L.A., Zeller J.M., Fiedel B.A., Kinoshita C.M., and Gewurz H. Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity. Inflammation 12 (1988) 391-405
20. Wang H.W., and Sui S.F. Dissociation and subunit rearrangement of membrane-bound human C-reactive proteins. Biochem. Biophys. Res. Commun. 288 (2001) 75-79
21. Motie M., Brockmeier S., and Potempa L.A. Binding of model soluble immune complexes to modified C-reactive protein. J. Immunol. 156 (1996) 4435-4441
22. Khreiss T., Jozsef L., Potempa L.A., and Filep J.G. Opposing effects of C-reactive protein isoforms on shear-induced neutrophil-platelet adhesion and neutrophil aggregation in whole blood. Circulation 110 (2004) 2713-2720
23. Miyazawa K., Kiyono S., and Inoue K. Modulation of stimulus-dependent human platelet activation by C-reactive protein modified with active oxygen species. J. Immunol. 141 (1988) 570-574
24. Potempa L.A., Motie M., Wright K.E., Crump B.L., Radosevich J.A., Sakai N., Lai G., Tanaka K., Kojima E., and Tsuboi A. Stimulation of megakaryocytopoiesis in mice by human modified C-reactive protein (mCRP). Exp. Hematol. 24 (1996) 258-264
25. Jiang H.X., Siegel J.N., and Gewurz H. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q. J. Immunol. 146 (1991) 2324-2330
26. Vaith P., Prasauskas V., Potempa L.A., and Peter H.H. Complement activation by C-reactive protein on the HEp-2 cell substrate. Int. Arch. Allergy Immunol. 111 (1996) 107-117
27. Kern W., and Puotinen D.A. Cleaning solutions based on hydrogen peroxide for use in silicon semiconductor technology. RCA Rev. 31 (1970) 187-206
28. In: Azzam R.M., and Bashara N.M. (Eds). Ellipsometry and Polarized Light. second ed. (1987), Elsevier, Amsterdam
29. Potempa L.A., Maldonado B.A., Laurent P., Zemel E.S., and Gewurz H. Antigenic, electrophoretic and binding alterations of human C-reactive protein modified selectively in the absence of calcium. Mol. Immunol. 20 (1983) 1165-1175
30. Ying S.C., Shephard E., de Beer F.C., Siegel J.N., Harris D., Gewurz B.E., Fridkin M., and Gewurz H. Localization of sequence-determined neoepitopes and neutrophil digestion fragments of C-reactive protein utilizing monoclonal antibodies and synthetic peptides. Mol. Immunol. 29 (1992) 677-687
31. Vroman L., and Lukosevicius A. Ellipsometer recordings of changes in optical thickness of adsorbed films associated with surface activation of blood clotting. Nature 204 (1964) 701-703
32. F.L. McCrackin, A fortran program for the analysis of ellipsometer measurements, NBS Tech. Note No. 479, Washington DC, 1969.
33. De Feijter J.A., Benjamins J., and Veer F.A. Ellipsometry as a tool to study adsorption behaviour of synthetic and biopolymers at air-water interface. Biopolymers 17 (1978) 1759-1772
34. Stenberg M., and Nygren H. A receptor-ligand reaction studied by a novel analytical tool-the isoscope ellipsometer. Anal. Biochem. 127 (1982) 183-192
35. Benesch J., Askendal A., and Tengvall P. Quantification of adsorbed human serum albumin at solid interfaces: a comparison between radioimmunoassay (RIA) and simple null ellipsometry. Colloids Surf. B, Biointerfaces 18 (2000) 71-81
36. Tengvall P., Askendal A., and Lundström I. Temporal studies on the deposition of complement on human colostrum IgA and serum IgG immobilized on methylated silicon. J. Biomed. Mater. Res. 35 (1997) 81-92
37. Wolbink G.J., Brouwer M.C., Buysmann S., ten Berge I.J., and Hack C.E. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. J. Immunol. 157 (1996) 473-479
38. Lagrand W.K., Niessen H.W., Wolbink G.J., Jaspars L.H., Visser C.A., Verheugt F.W., Meijer C.J., and Hack C.E. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 95 (1997) 97-103
39. Speidl W.S., Exner M., Amighi J., Kastl S.P., Zorn G., Maurer G., Wagner O., Huber K., Minar E., Wojta J., and Schillinger M. Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis. Eur. Heart J. 26 (2005) 2294-2299
40. Chang M.K., Binder C.J., Torzewski M., and Witztum J.L. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc. Natl. Acad. Sci. USA 99 (2002) 13043-13048
41. Mold C., Gewurz H., and Du Clos T.W. Regulation of complement activation by C-reactive protein. Immunopharmacology 42 (1999) 23-30
42. Gershov D., Kim S., Brot N., and Elkon K.B. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J. Exp. Med. 192 (2000) 1353-1364
43. Hesselink D.A., Aarden L.A., and Swaak A.J. Profiles of the acute-phase reactants C-reactive protein and ferritin related to the disease course of patients with systemic lupus erythematosus. Scand. J. Rheumatol. 32 (2003) 151-155
44. Rodriguez W., Mold C., Kataranovski M., Hutt J., Marnell L.L., and Du Clos T.W. Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein. Arthritis Rheum. 52 (2005) 642-650
45. Sjöwall C., Eriksson P., Almer S., and Skogh T. Autoantibodies to C-reactive protein is a common finding in SLE, but not in primary Sjögren's syndrome, rheumatoid arthritis or inflammatory bowel disease. J. Autoimmun. 19 (2002) 155-160
46. Sjöwall C., Bengtsson A.A., Sturfelt G., and Skogh T. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus. Arthritis Res. Ther. 6 (2004) R87-R94
47. Miyazawa K., and Inoue K. Complement activation induced by human C-reactive protein in mildly acidic conditions. J. Immunol. 145 (1990) 650-654
48. Ji S.R., Wu Y., Potempa L.A., Liang Y.H., and Zhao J. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 935-941